Literature DB >> 19776742

The expanding universe of p53 targets.

Daniel Menendez1, Alberto Inga, Michael A Resnick.   

Abstract

The p53 tumour suppressor is modified through mutation or changes in expression in most cancers, leading to the altered regulation of hundreds of genes that are directly influenced by this sequence-specific transcription factor. Central to the p53 master regulatory network are the target response element (RE) sequences. The extent of p53 transactivation and transcriptional repression is influenced by many factors, including p53 levels, cofactors and the specific RE sequences, all of which contribute to the role that p53 has in the aetiology of cancer. This Review describes the identification and functionality of REs and highlights the inclusion of non-canonical REs that expand the universe of genes and regulation mechanisms in the p53 tumour suppressor network.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19776742     DOI: 10.1038/nrc2730

Source DB:  PubMed          Journal:  Nat Rev Cancer        ISSN: 1474-175X            Impact factor:   60.716


  201 in total

1.  Analysis of p53-regulated gene expression patterns using oligonucleotide arrays.

Authors:  R Zhao; K Gish; M Murphy; Y Yin; D Notterman; W H Hoffman; E Tom; D H Mack; A J Levine
Journal:  Genes Dev       Date:  2000-04-15       Impact factor: 11.361

2.  Mechanistic insights into maintenance of high p53 acetylation by PTEN.

Authors:  Andrew G Li; Landon G Piluso; Xin Cai; Gang Wei; William R Sellers; Xuan Liu
Journal:  Mol Cell       Date:  2006-08       Impact factor: 17.970

3.  p53-mediated inhibition of angiogenesis through up-regulation of a collagen prolyl hydroxylase.

Authors:  Jose G Teodoro; Albert E Parker; Xiaochun Zhu; Michael R Green
Journal:  Science       Date:  2006-08-18       Impact factor: 47.728

4.  p53 domains: identification and characterization of two autonomous DNA-binding regions.

Authors:  Y Wang; M Reed; P Wang; J E Stenger; G Mayr; M E Anderson; J F Schwedes; P Tegtmeyer
Journal:  Genes Dev       Date:  1993-12       Impact factor: 11.361

5.  Transcriptional regulation of the human DNA polymerase delta catalytic subunit gene POLD1 by p53 tumor suppressor and Sp1.

Authors:  B Li; M Y Lee
Journal:  J Biol Chem       Date:  2001-05-25       Impact factor: 5.157

6.  Mdm2 regulates p53 mRNA translation through inhibitory interactions with ribosomal protein L26.

Authors:  Yaara Ofir-Rosenfeld; Kristy Boggs; Dan Michael; Michael B Kastan; Moshe Oren
Journal:  Mol Cell       Date:  2008-10-24       Impact factor: 17.970

7.  Negative regulation of Chk2 expression by p53 is dependent on the CCAAT-binding transcription factor NF-Y.

Authors:  Taido Matsui; Yuko Katsuno; Tomoharu Inoue; Fumitaka Fujita; Takashi Joh; Hiroyuki Niida; Hiroshi Murakami; Makoto Itoh; Makoto Nakanishi
Journal:  J Biol Chem       Date:  2004-03-25       Impact factor: 5.157

8.  Negative feedback regulation of wild-type p53 biosynthesis.

Authors:  J Mosner; T Mummenbrauer; C Bauer; G Sczakiel; F Grosse; W Deppert
Journal:  EMBO J       Date:  1995-09-15       Impact factor: 11.598

9.  Differential transactivation by the p53 transcription factor is highly dependent on p53 level and promoter target sequence.

Authors:  Alberto Inga; Francesca Storici; Thomas A Darden; Michael A Resnick
Journal:  Mol Cell Biol       Date:  2002-12       Impact factor: 4.272

10.  A new p38 MAP kinase-regulated transcriptional coactivator that stimulates p53-dependent apoptosis.

Authors:  Ana Cuadrado; Vanesa Lafarga; Peter C F Cheung; Ignacio Dolado; Susana Llanos; Philip Cohen; Angel R Nebreda
Journal:  EMBO J       Date:  2007-03-22       Impact factor: 11.598

View more
  290 in total

Review 1.  MicroRNAs, wild-type and mutant p53: more questions than answers.

Authors:  Matthew Jones; Ashish Lal
Journal:  RNA Biol       Date:  2012-06-01       Impact factor: 4.652

2.  Functional mimicry of the acetylated C-terminal tail of p53 by a SUMO-1 acetylated domain, SAD.

Authors:  Amrita Cheema; Chad D Knights; Mahadev Rao; Jason Catania; Ricardo Perez; Brigitte Simons; Sivanesan Dakshanamurthy; Vamsi K Kolukula; Maddalena Tilli; Priscilla A Furth; Christopher Albanese; Maria Laura Avantaggiati
Journal:  J Cell Physiol       Date:  2010-11       Impact factor: 6.384

3.  MAP/ERK kinase kinase 1 (MEKK1) mediates transcriptional repression by interacting with polycystic kidney disease-1 (PKD1) promoter-bound p53 tumor suppressor protein.

Authors:  M Rafiq Islam; Tamara Jimenez; Christopher Pelham; Marianna Rodova; Sanjeev Puri; Brenda S Magenheimer; Robin L Maser; Christian Widmann; James P Calvet
Journal:  J Biol Chem       Date:  2010-10-05       Impact factor: 5.157

4.  Structure of p73 DNA-binding domain tetramer modulates p73 transactivation.

Authors:  Abdul S Ethayathulla; Pui-Wah Tse; Paola Monti; Sonha Nguyen; Alberto Inga; Gilberto Fronza; Hector Viadiu
Journal:  Proc Natl Acad Sci U S A       Date:  2012-04-02       Impact factor: 11.205

5.  Complex regulation of p73 isoforms after alteration of amyloid precursor polypeptide (APP) function and DNA damage in neurons.

Authors:  Samir Benosman; Xiangjun Meng; Yannick Von Grabowiecki; Lavinia Palamiuc; Lucian Hritcu; Isabelle Gross; Georg Mellitzer; Yoichi Taya; Jean-Philippe Loeffler; Christian Gaiddon
Journal:  J Biol Chem       Date:  2011-10-14       Impact factor: 5.157

6.  A small kiss of death for cancer.

Authors:  Angelika Eggert; Johannes H Schulte
Journal:  Nat Med       Date:  2010-10       Impact factor: 53.440

Review 7.  p53 at a glance.

Authors:  Colleen A Brady; Laura D Attardi
Journal:  J Cell Sci       Date:  2010-08-01       Impact factor: 5.285

8.  Panhistone deacetylase inhibitors inhibit proinflammatory signaling pathways to ameliorate interleukin-18-induced cardiac hypertrophy.

Authors:  Gipsy Majumdar; Robert J Rooney; I Maria Johnson; Rajendra Raghow
Journal:  Physiol Genomics       Date:  2011-09-27       Impact factor: 3.107

Review 9.  Emerging roles of p53 and other tumour-suppressor genes in immune regulation.

Authors:  César Muñoz-Fontela; Anna Mandinova; Stuart A Aaronson; Sam W Lee
Journal:  Nat Rev Immunol       Date:  2016-09-26       Impact factor: 53.106

10.  Bridged Analogues for p53-Dependent Cancer Therapy Obtained by S-Alkylation.

Authors:  Ewa D Micewicz; Shantanu Sharma; Alan J Waring; Hai T Luong; William H McBride; Piotr Ruchala
Journal:  Int J Pept Res Ther       Date:  2015-08-19       Impact factor: 1.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.